ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 489,35
0,59%
Dow Jones
42 677,05
-0,07%
DAX
20 340,57
0,65%
Brent Oil
77,02
1,19%
Bitcoin
97 331,39
-4,84%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Protagenic Therapeutics Inc (PTIX)

  7. Protagenic Therapeutics Inc (PTIX) Actualités

PTIX

Protagenic Therapeutics (PTIX)

Protagenic Therapeutics Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:PTIX
DateHeureSourceTitreSymboleSociété
14/08/202422h59Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:PTIXProtagenic Therapeutics Inc
26/07/202423h30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PTIXProtagenic Therapeutics Inc
14/02/202420h29Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:PTIXProtagenic Therapeutics Inc
02/11/202321h29Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:PTIXProtagenic Therapeutics Inc
13/10/202318h48Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PTIXProtagenic Therapeutics Inc
17/04/202320h44Edgar (US Regulatory)Amended Annual Report (10-k/a)NASDAQ:PTIXProtagenic Therapeutics Inc
22/03/202318h29Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PTIXProtagenic Therapeutics Inc
14/11/202220h20Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:PTIXProtagenic Therapeutics Inc
12/10/202212h01Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:PTIXProtagenic Therapeutics Inc
08/03/202222h03Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:PTIXProtagenic Therapeutics Inc
15/02/202212h17Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:PTIXProtagenic Therapeutics Inc
04/02/202222h33Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:PTIXProtagenic Therapeutics Inc
23/11/202114h45TipRanksProtagenic Therapeutics (PTIX) Initiated with a Buy at Maxim GroupNASDAQ:PTIXProtagenic Therapeutics Inc
16/11/202115h58GlobeNewswire Inc.Protagenic Therapeutics Announces Third Quarter 2021 Results and Business UpdateNASDAQ:PTIXProtagenic Therapeutics Inc
10/09/202122h57Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3/a)NASDAQ:PTIXProtagenic Therapeutics Inc
30/08/202115h15GlobeNewswire Inc.Protagenic Therapeutics to Host Virtual Science Review Wednesday, September 8th at 10 AM ETNASDAQ:PTIXProtagenic Therapeutics Inc
17/08/202113h45GlobeNewswire Inc.Protagenic Therapeutics Announces Second Quarter 2021 Results and Provides Business UpdateNASDAQ:PTIXProtagenic Therapeutics Inc
13/08/202123h29Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:PTIXProtagenic Therapeutics Inc
23/07/202122h21GlobeNewswire Inc.Protagenic Therapeutics Updates Timeline for Commencement of Patient Enrollment for PT00114 Clinical TrialNASDAQ:PTIXProtagenic Therapeutics Inc
06/07/202112h17GlobeNewswire Inc.Protagenic Therapeutics to Host Webinar with Dr. Maurizio Fava for its Lead Molecule PT00114 on Tuesday, July 13th at 10:00 A...NASDAQ:PTIXProtagenic Therapeutics Inc
02/07/202122h48Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:PTIXProtagenic Therapeutics Inc
16/06/202115h15GlobeNewswire Inc.Protagenic Therapeutics to Present at the H.C. Wainwright Psychedelics in Psychiatry and Beyond Virtual Conference on June 17...NASDAQ:PTIXProtagenic Therapeutics Inc
04/06/202100h13Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PTIXProtagenic Therapeutics Inc
29/04/202121h06GlobeNewswire Inc.Protagenic Therapeutics, Inc. Announces Closing of $13.2 Million Public Offering and Uplisting to NasdaqNASDAQ:PTIXProtagenic Therapeutics Inc
28/04/202123h30Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(4) (424b4)NASDAQ:PTIXProtagenic Therapeutics Inc
27/04/202102h58GlobeNewswire Inc.Protagenic Therapeutics, Inc. Announces Nasdaq Uplisting and Pricing of $13.2 Million Public OfferingNASDAQ:PTIXProtagenic Therapeutics Inc
13/02/201012h00PR Newswire (US)Performance Technologies Announces Rebranding of Company to PTNASDAQ:PTIX
12/02/201015h00PR Newswire (US)Performance Technologies Debuts NGN Xpress(TM) Product LineNASDAQ:PTIX
11/02/201014h00PR Newswire (US)Comfone Expands International Connectivity with Performance Technologies' SEGway(TM) Signalling SolutionNASDAQ:PTIX
27/01/201016h48PR Newswire (US)Performance Technologies Schedules Fourth Quarter 2009 Year End Earnings Release and Conference CallNASDAQ:PTIX
 Showing the most relevant articles for your search:NASDAQ:PTIX

Dernières Valeurs Consultées

EU
ACA
Credit Agricole
NASDAQ
NVDA
NVIDIA
FTSE
UKX
FTSE 100
USI
USTECH100
US Tech 100
EU
CS
Axa
EU
PX1
CAC 40
EU
ML
Michelin
NASDAQ
GOOGL
Alphabet
NASDAQ
AMZN
Amazon.com
EU
RI
Pernod Ricard
EU
VIV
Vivendi
COIN
AVAXUSD
Avalanche
EU
VK
Vallourec
EU
MC
Lvmh Moet Hennessy Louis...
EU
RNO
Renault
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés